Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Umbilical cord mesenchymal stem cell transplantation for hereditary cerebellar ataxia
ChiCTR-ONRC-12001869Phase 2Completed
- Sponsor
- The Third Medical Center of the Chinese People's Liberation Army General Hospital
- Start
- Jan 2012
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label trial of human umbilical cord derived mesenchymal stem cells in Genetic Ataxias and spinocerebellar ataxia type 1 (SCA1) (2 arms), sponsored by The Third Medical Center of the Chinese People's Liberation Army General Hospital. Primary endpoint: Nerve functional evaluation. Started Jan 2012; status: completed.
02
Drugs
human umbilical cord derived mesenchymal stem cells
03
Conditions
Genetic Ataxiasspinocerebellar ataxia type 1 (SCA1)
Beyond the preview
Go deeper on ChiCTR-ONRC-12001869.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-ONRC-12001869.